Tandem Diabetes Care said its Tandem Mobi automated insulin delivery system can now be used with compatible Android smartphones in the U.S. via the Tandem Mobi mobile app. The company said the system uses Control-IQ+ technology and cited reported outcomes including day 1 improvements, 79% time in range, and 90% overnight time in range. Tandem said the Android version of the app was cleared by the U.S. Food and Drug Administration in November 2025 and had a limited release in December 2025, and that the app is available on Google Play for compatible Google Pixel 6 through 10 and Samsung Galaxy S21 through S25 models.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tandem Diabetes Care Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202603041700BIZWIRE_USPR_____20260304_BW073769) on March 04, 2026, and is solely responsible for the information contained therein.
Comments